Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.
Navigenics, ImaGenes, Ocimum Biosolutions
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.